Your browser doesn't support javascript.
loading
Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19.
Tran, Thi Nhu Mai; May, Bruce Pearson; Ung, Trong Thuan; Nguyen, Mai Khoi; Nguyen, Thi Thuy Trang; Dinh, Van Long; Doan, Chinh Chung; Tran, The Vinh; Khong, Hiep; Nguyen, Thi Thanh Truc; Hua, Hoang Quoc Huy; Nguyen, Viet Anh; Ha, Tan Phat; Phan, Dang Luu; Nguyen, Truong An; Bui, Thi Ngoc; Tu, Tieu My; Nguyen, Thi Theo; Le, Thi Thuy Hang; Dong, Thi Lan; Huynh, Trong Hieu; Ho, Phien Huong; Le, Nguyen Thanh Thao; Truong, Cong Thao; Pham, Hoang Phi; Luong, Cong Y; Y, Nie Lim; Cao, Minh Ngoc; Nguyen, Duy Khanh; Le, Thi Thanh; Vuong, Duc Cuong; Nguyen, Le Khanh Hang; Do, Minh Si.
Afiliação
  • Tran TNM; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • May BP; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Ung TT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen MK; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen TTT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Dinh VL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Doan CC; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Tran TV; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Khong H; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen TTT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Hua HQH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen VA; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Ha TP; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Phan DL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen TA; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Bui TN; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Tu TM; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen TT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Le TTH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Dong TL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Huynh TH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Ho PH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Le NTT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Truong CT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Pham HP; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Luong CY; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Y NL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Cao MN; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Nguyen DK; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
  • Le TT; Department of Virology, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam.
  • Vuong DC; Department of Virology, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam.
  • Nguyen LKH; Department of Virology, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam.
  • Do MS; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.
Front Immunol ; 12: 766112, 2021.
Article em En | MEDLINE | ID: mdl-34938290
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Vietnã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Vietnã